Skip to main content
. 2021 Apr 20;13(4):587. doi: 10.3390/pharmaceutics13040587

Table 4.

The most important characteristics of different CS-LPs (selection).

CS-LPs LPs Size (nm) DLE
(%)
DR
(%)
Mw/DD
of CS
ZP (mV) Ref.
Curcumin
hybrid MCS-LPs
54.1 ± 2.4 8.08 ± 0.18% 13.1% (after 12 h)
15.5% (after 24 h)
CMCS Mw
10 kDa
DD 85%
26.3 ± 2.3 [73]
Glutathion/Ferulic acid CS-LPs 460.3 ± 6.0 Gluthation: 61.32 ± 1.32; Ferrulic acid:
68.92 ± 1.27
- CS LMw
100 kDa
DD ≥ 95%
57.7 ± 1.3 [75]
N acetyl Cys CS-LPs (DPPG 5% CS: lipid ratio 1:1) 610.08 ± 8.3 74 ± 1.73% 38% (after 7 h) CS Mw
110–150 kDa
DD ≤ 40%
38.1 ± 0.9 [72]
Acteoside CS-LPs 92.77 ± 2.99 88.10 ± 5.36% 54.82% (after 4 h)
67.34% (after 8 h)
CS LMw
100 kDa
DD ≥ 95%
19.65 ± 0.9 [74]
Triamcinolone acetonide
CS-LPs
100.3 ± 6.8 98 ± 5.36% - CS LMw
100 kDa
DD *
31.2 ± 0.8 [81]
Curcumin thiolated CS-LPs 406.0 ± 12.0 93.95 ± 3.94% 40.39% (pH 5.5, after 12 h);
24.93% (pH 7.4, after 12 h)
CS MMw,
DD 78%
36.6 ± 0.6 [76]

* unspecified.